Viable adenovirus vaccine prototypes: High-level production of a papillomavirus capsid antigen from the major late transcriptional unit

Proceedings of the National Academy of Sciences of the United States of America

Volumn 102, Issue 12, 2005, Pages 4590-4595

  Berg, Michael ^a   DiFatta, Julie ^a,c   Hoiczyk, Egbert ^a   Schlegel, Richard ^b   Ketner, Gary ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^c Department of Justice ^*  (United States)

Author keywords

Late gene expression; Viable recombinant; Virus like particle

Indexed keywords

ADENOVIRUS VACCINE; ADENOVIRUS VECTOR; CAPSID PROTEIN; EPITOPE; L1 PROTEIN; LIVE VACCINE; MESSENGER RNA; RECOMBINANT L1 PROTEIN; RECOMBINANT LIVE VACCINE; RECOMBINANT PROTEIN; RECOMBINANT VACCINE; UNCLASSIFIED DRUG; VIRUS CAPSID ANTIGEN; VIRUS PROTEIN; VIRUS VACCINE;

ADENOVIRUS LATE REGION 5; ANTIGEN ANTIBODY REACTION; ARTICLE; CANINE ORAL PAPILLOMA VIRUS; DNA INTEGRATION; GENE EXPRESSION; GENE ORDER; IMMUNITY; IMMUNOGENICITY; IN VIVO STUDY; LATE GENE EXPRESSION; MAJOR LATE TRANSCRIPTIONAL UNIT; MUCOSA INFECTION; NONHUMAN; PAPILLOMA VIRUS; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN CONFORMATION; PROTEIN SYNTHESIS; RNA PROCESSING; RNA SPLICING; VIRUS GENE; VIRUS GENOME; VIRUS HEXON; VIRUS INFECTION; VIRUS PARTICLE; VIRUS RECOMBINANT; VIRUS TRANSCRIPTION;

ADENOVIRIDAE; ANIMALS; ANTIGENS, VIRAL; CAPSID PROTEINS; DOG DISEASES; DOGS; GENE EXPRESSION; GENES, VIRAL; GENETIC VECTORS; HUMANS; MICROSCOPY, ELECTRON; MUTAGENESIS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PROTEIN CONFORMATION; RECOMBINANT PROTEINS; RECOMBINATION, GENETIC; RNA, MESSENGER; RNA, VIRAL; VIRAL VACCINES;

ADENOVIRIDAE; ANIMALIA; CANINE ORAL PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS; MIRIDAE; PAPILLOMAVIRUS;

EID: 15444362351     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0500933102     Document Type: Article

References (45)

1. Gaydos, C. A. & Gaydos, J. C. (2004) in Vaccines, eds. Plotkin, S. A. & Orenstein, M. D. (Saunders, Philadelphia), pp. 863-885.
2. Tatsis, N. & Ertl, H. C. (2004) Mol. Ther. 10, 616-629.
3. Bosch, F. X., Lorincz, A., Munoz, N., Meijer, C. J. & Shah, K. V. (2002) J. Clin. Pathol. 55, 244-265.
4. Breitburd, F., Kirnbauer, R., Hubbert, N. L., Nonnenmacher, B., Trin-Dinh-Desmarquet, C., Orth, G., Schiller, J. T. & Lowy, D. R. (1995) J. Virol. 69, 3959-3963.
5. Suzich, J. A., Ghim, S. J., Palmer-Hill, F. J., White, W. I., Tamura, J. K., Bell, J. A., Newsome, J. A., Jenson, A. B. & Schlegel, R. (1995) Proc. Natl. Acad. Sci. USA 92, 11553-11557.
6. Kirnbauer, R., Chandrachud, L. M., O'Neil, B. W., Wagner, E. R., Grindlay, G. J., Armstrong, A., McGarvie, G. M., Schiller, J. T., Lowy, D. R. & Campo, M. S. (1996) Virology 219, 37-44.
7. Harro, C. D., Pang, Y. Y., Roden, R. B., Hildesheim, A., Wang, Z., Reynolds, M. J., Mast, T. C., Robinson, R., Murphy, B. R., Karron, R. A., et al. (2001) J. Natl. Cancer Inst. 93, 284-292.
8. Pinto, L. A., Edwards, J., Castle, P. E., Harro, C. D., Lowy, D. R., Schiller, J. T., Wallace, D., Kopp, W., Adelsberger, J. W., Baseler, M. W., et al. (2003) J. Infect. Dis. 188, 327-338.
9. Koutsky, L. A., Ault, K. A., Wheeler, C. M., Brown, D. R., Barr, E., Alvarez, F. B., Chiacchierini, L. M. & Jansen, K. U. (2002) N. Engl. J. Med. 347, 1645-1651.
10. Bosch, F. X. & de Sanjose, S. (2003) J. Natl. Cancer Inst. Monogr., 3-13.
11. Chengalvala, M., Lubeck, M. D., Davis, A. R., Mizutani, S., Molnar-Kimber, K., Morin, J. & Hung, P. P. (1991) Vaccine 9, 485-490.
12. Chen, Y., Ghim, S. J., Jenson, A. B. & Schlegel, R. (1998) J. Gen. Virol. 79, 2137-2146.
13. Ketner, G., Spencer, F., Tugendreich, S., Connelly, C. & Hieter, P. (1994) Proc. Natl. Acad. Sci. USA 91, 6186-6190.
14. Von Seggern, D. J., Chiu, C. Y., Fleck, S. K., Stewart, P. L. & Nemerow, G. R. (1999) J. Virol. 73, 1601-1608.
15. Sambrook, J., Fritsch, E. F. & Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual (Cold Spring Harbor Lab. Press, Woodbury, NY).
16. Ketner, G. & Boyer, J. (1998) in Adenovirus Methods and Protocols, ed. Wold, W. S. M. (Humana, Totowa, NJ).
17. Hultgren, S. J., Porter, T. N., Schaeffer, A. J. & Duncan, J. L. (1985) Infect. Immun. 50, 370-377.
18. Shenk, T. (2002) in Fundamental Virology, eds. Knipe, D. M. & Howlet, P. M. (Lippincott, Philadelphia), pp. 1053-1088.
19. Rivera, A. A., Wang, M., Suzuki, K., Uil, T. G., Krasnykh, V., Curiel, D. T. & Nettelbeck, D. M. (2004) Virology 320, 121-134.
20. Sauthoff, H., Pipiya, T., Heitner, S., Chen, S., Norman, R. G., Rom, W. N. & Hay, J. G. (2002) Hum. Gene Ther. 13, 1859-1871.
21. Ghim, S. J., Jenson, A. B. & Schlegel, R. (1992) Virology 190, 548-552.
22. Collier, B., Oberg, D., Zhao, X. & Schwartz, S. (2002) J. Virol. 76, 2739-2752.
23. Zheng, Z. M., He, P. & Baker, C. C. (1996) J. Virol. 70, 4691-4699.
24. Furth, P. A., Choe, W. T., Rex, J. H., Byrne, J. C. & Baker, C. C. (1994) Mol. Cell. Biol. 14, 5278-5289.
25. Kennedy, I. M., Haddow, J. K. & Clements, J. B. (1991) J. Virol. 65, 2093-2097.
26. Sokolowski, M., Zhao, C., Tan, W. & Schwartz, S. (1997) Oncogene 15, 2303-2319.
27. Zheng, Z. M., He, P. J. & Baker, C. C. (1999) J. Virol. 73, 29-36.
28. Muhlemann, O., Kreivi, J. P. & Akusjarvi, G. (1995) J. Virol. 69, 7324-7327.
29. Perez, I., Lin, C. H., McAfee, J. G. & Patton, J. G. (1997) RNA 3, 764-778.
30. Cartegni, L., Wang, J., Zhu, Z., Zhang, M. Q. & Krainer, A. R. (2003) Nucleic Acids Res. 31, 3568-3571.
31. Top, F. H., Jr., Grossman, R. A., Bartelloni, P. J., Segal, H. E., Dudding, B. A., Russell, P. K. & Buescher, E. L. (1971) J. Infect. Dis. 124, 148-154.
32. Dudding, B. A., Bartelloni, P. J., Scott, R. M., Top, F. H., Jr., Russell, P. K. & Buescher, E. L. (1972) Infect. Immun. 5, 295-299.
33. Rhoads, J. L., Birx, D. L., Wright, D. C., Brundage, J. F., Brandt, B. L., Redfield, R. R. & Burke, D. S. (1991) J. Acquired Immune Defic. Syndr. 4, 724-731.
34. Rodrigues, E. G., Zavala, F., Eichinger, D., Wilson, J. M. & Tsuji, M. (1997) J. Immunol. 158, 1268-1274.
35. Sullivan, N. J., Sanchez, A., Rollin, P. E., Yang, Z. Y. & Nabel, G. J. (2000) Nature 408, 605-609.
36. Tobery, T. W., Smith, J. F., Kuklin, N., Skulsky, D., Ackerson, C., Huang, L., Chen, L., Cook, J. C., McClements, W. L. & Jansen, K. U. (2003) Vaccine 21, 1539-1547.
37. Natuk, R. J., Chanda, P. K., Lubeck, M. D., Davis, A. R., Wilhelm, J., Hjorth, R., Wade, M. S., Bhat, B. M., Mizutani, S., Lee, S., et al. (1992) Proc. Natl. Acad. Sci. USA 89, 7777-7781.
38. Lubeck, M. D., Natuk, R., Myagkikh, M., Kalyan, N., Aldrich, K., Sinangil, F., Alipanah, S., Murthy, S. C., Chanda, P. K., Nigida, S. M., Jr., et al. (1997) Nat. Med. 3, 651-658.
39. Buge, S. L., Richardson, E., Alipanah, S., Markham, P., Cheng, S., Kalyan, N., Miller, C. J., Lubeck, M., Udem, S., Eldridge, J. & Robert-Guroff, M. (1997) J. Virol. 71, 8531-8541.
40. Patterson, L. J., Malkevitch, N., Venzon, D., Pinczewski, J., Gomez-Roman, V. R., Wang, L., Kalyanaraman, V. S., Markham, P. D., Robey, F. A. & Robert-Guroff, M. (2004) J. Virol. 78, 2212-2221.
41. Patterson, L. J., Prince, G. A., Richardson, E., Alvord, W. G., Kalyan, N. & Robert-Guroff, M. (2002) Virology 292, 107-113.
42. Xiang, Z. Q., Gao, G. P., Reyes-Sandoval, A., Li, Y., Wilson, J. M. & Ertl, H. C. (2003) J. Virol. 77, 10780-10789.
43. Vogels, R., Zuijdgeest, D., van Rijnsoever, R., Hartkoorn, E., Damen, I., de Bethune, M. P., Kostense, S., Penders, G., Helmus, N., Koudstaal, W., et al. (2003) J. Virol. 77, 8263-8271.
44. Kovacs, G. M., Davison, A. J., Zakhartchouk, A. N. & Harrach, B. (2004) J. Gen. Virol. 85, 2799-2807.
45. Zhao, X., Rush, M. & Schwartz, S. (2004) J. Virol. 78, 10888-10905.